Press releases
- AbCellera Presents Data on T-Cell Engagers Against Four Tumor Targets at AACR 2024
- AbCellera to Report First Quarter 2024 Financial Results on May 7, 2024
- AbCellera to Present at the Bloom Burton Healthcare Conference on April 16, 2024
- AbCellera to Collaborate with Biogen to Discover Therapeutic Antibodies for Neurological Conditions
- AbCellera Announces Four Presentations on T-Cell Engagers at AACR 2024
- AbCellera Announces Resignation of Board Member
- AbCellera to Present at Upcoming Investor Conferences in March
- AbCellera Reports Full Year 2023 Business Results
More ▼
Key statistics
On Tuesday, Abcellera Biologics Inc (8QQ:HAM) closed at 3.73, 5.01% above its 52-week low of 3.56, set on Nov 03, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 3.73 |
---|---|
High | 3.73 |
Low | 3.73 |
Bid | 3.71 |
Offer | 3.74 |
Previous close | 3.61 |
Average volume | 0.00 |
---|---|
Shares outstanding | 292.78m |
Free float | 210.50m |
P/E (TTM) | -- |
Market cap | 1.17bn USD |
EPS (TTM) | -0.5062 USD |
Data delayed at least 15 minutes, as of Apr 23 2024 07:00 BST.
More ▼